Advertisement

Lipid Management for the Prevention of Cardiovascular Disease.

09:38 EDT 23rd May 2013 | BioPortfolio

Summary of "Lipid Management for the Prevention of Cardiovascular Disease."

Lowering low density lipoprotein (LDL) - cholesterol is one of the key issues in modern preventive cardiology by which we are able to interact with the natural course of atherosclerosis. Diet and healthy life style are mandatory for the treatment of CAD high risk patients. Numerous lipid lowering trials confirmed the beneficial effect of statins in primary as well as secondary prevention. By this statins are the basic treatment in patients with coronary artery disease (CAD) or diabetes mellitus or both. In order to reach LDL - cholesterol target levels (LDL - cholesterol < 100 mg/dl) in patients with CAD the use of potent statins or a lipid lowering combination therapy might be necessary to reach the LDL target level. In our days we are able to lower LDL-cholesterol by more than 50% with drug treatment, which should enable us to reach the optimal LDL-cholesterol level in most patients.

Affiliation

Philipps-University of Marburg, Internal Medicine - Cardiology, UKGM Standort Marburg, D-35033 Marburg, Germany. schafer5@staff.uni-marburg.de.

Journal Details

This article was published in the following journal.

Name: Current pharmaceutical design
ISSN: 1873-4286
Pages:

Links

Medical and Biotech [MESH] Definitions

Primary Prevention

Specific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from SECONDARY PREVENTION and TERTIARY PREVENTION.

Secondary Prevention

The prevention of recurrences or exacerbations of a disease that already has been diagnosed. This also includes prevention of complications or after-effects of a drug or surgical procedure.

Pregnancy Complications, Cardiovascular

The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.

Centers For Disease Control And Prevention (u.s.)

An agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries.

Preventive Medicine

A medical specialty primarily concerned with prevention of disease (PRIMARY PREVENTION) and the promotion and preservation of health in the individual.

PubMed Articles [ 27204 Associated PubMed Articles listed on BioPortfolio]

Therapy of dyslipidemia in rheumatic diseases.

Cardiovascular diseases are the main cause of death worldwide and dyslipidemia constitutes a substantial risk factor. Patients with rheumatic diseases, especially active inflammatory arthritis and sys...

Prevention: Cost-effectiveness of cardiovascular disease prevention and management in the developing world.

Optimizing the Use of Aspirin for Cardiovascular Prevention.

This article describes the mechanism of action, pharmacokinetics, and pharmacodynamics of aspirin at doses used for cardiovascular prevention and provides specific management recommendations for optim...

Optimal Medical Therapy, Lifestyle Intervention, and Secondary Prevention Strategies for Cardiovascular Event Reduction in Ischemic Heart Disease.

Medical and lifestyle secondary prevention strategies are essential components for reducing cardiovascular risk, irrespective of whether revascularization is performed. In patients with coronary arter...

Lipid oxidation and cardiovascular disease: introduction to a review series.

Clinical Trials [ 6055 Associated Clinical Trials listed on BioPortfolio]

Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a)

Lipoprotein(a) [Lp(a)] is an independent risk factor for cardiovascular disease. Non-medical treatment measures (e.g. dietary therapy or weight loss) can hardly influence Lp(a) plasma conc...

Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis

Psoriasis patients are known to be at increased risk for heart disease. This may be due to the increased prevalence of cardiovascular disease risk factors in this population, including hi...

From Research to Practice - Lipid Management for Low HDL-Cholesterol

The overall purpose of this project is to improve the clinical outcomes of veterans with ischemic heart disease (IHD) through implementation of evidence-based lipid management, with a part...

Studies of Apolipoprotein Genotyping on the Drug Treatment of Hyperlipidemic Patients

Cardiovascular-related diseases have been the majorities of the leading ten causes of death in Taiwan. Atherosclerotic cardiovascular diseases are multifactorial. Some non-modifiable risk...

Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs

The purpose of this study is to determine the effectiveness of maximal support of community pharmacies to implement a pharmaceutical care model for improving underprescription and treatmen...

Search BioPortfolio: